Stanford University
Showing 11,101-11,150 of 13,126 Results
-
Jacqueline Sunderland
Adm Assoc 4, Pediatrics - Endocrinology
Current Role at StanfordAdministrative Associate, Pediatric Endocrinology & Diabetes
-
Arthur Sung, MD, FCCP
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Sung is a highly esteemed, fellowship-trained interventional pulmonologist and a fellow of the American College of Chest Physicians.
He is the senior associate chief of the Stanford Medicine Division of Pulmonary, Allergy and Critical Care Medicine. He founded the interventional pulmonology and bronchoscopy for Stanford Medicine in 2013. With Stanford University School of Medicine, he is a clinical associate professor of medicine – pulmonary, allergy and critical care medicine.
In his clinical practice, Dr. Sung delivers care at Stanford Medicine sites in both Palo Alto, Emeryville and Livermore. He is a recognized expert in the diagnosis and treatment of conditions involving the chest and lungs, including complex airway diseases.
Patients praise the quality of his care and excellent listening skills. They highlight his ability to answer questions and to explain medical conditions and treatment options clearly and compassionately.
To advance the field of pulmonology, Dr. Sung is conducting research in airways diseases. He is a principal investigator of a study of variables in computed tomography imaging used to support diagnostic and treatment approaches. He previously served as the site principal investigator for lung volume reduction procedure for COPD.
Dr. Sung has co-authored articles published in the Journal of Thoracic Oncology, Clinical Lung Cancer, Journal of Thoracic Imaging, Chest, and elsewhere. Topics have included innovations in therapy for pneumonitis and robotic surgical treatment of lung tumors.
He has written chapters for books such as Principles and Practice of Interventional Pulmonology, Examination of the Larynx through the Bronchoscope, and Airway Anatomy for the Bronchoscopist.
Dr. Sung has made presentations to the American Thoracic Society, American College of Chest Physicians, and American Association of Bronchology and Interventional Pulmonology. Topics have included lung cancer staging in the era of personalized medicine.
Dr. Sung has earned recognition from the College of Chest Physicians. The Stanford Leadership Program has recognized his achievements. From the Stanford University Bio-X program, he received a grant to study ultrasound-guided lung biopsy procedures. The Bio-X program fosters interdisciplinary collaboration among biomedical and life science researchers, clinicians, engineers, physicists, and computational scientists.
He is a member of the American Thoracic Society, American College of Chest Physicians, and American Association of Bronchology and Interventional Pulmonology. He has volunteered his time and expertise to deliver health care services to those in need. New Orleans Mayor Ray Nagins honored Dr. Sung for providing care to victims of Hurricane Katrina. -
C. Kwang Sung, MD, MS
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Music
Current Research and Scholarly InterestsLaryngology
Otolaryngology
Professional voice -
Lily Sung, MD
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr. Lily Sung is a fellowship-trained immunologist and rheumatologist at Stanford Health Care. She also serves as a clinical assistant professor in the Department of Medicine, Division of Immunology & Rheumatology at Stanford University School of Medicine.
Dr. Sung specializes in diagnosing and treating patients with rheumatic diseases. She has special interest in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and lupus. Dr. Sung also treats patients with rare, chronic autoimmune diseases that involve muscle inflammation.
Dr. Sung’s research focuses on the impact of environmental exposures on rheumatic diseases and improving health outcomes in vulnerable populations. Her work has been published in peer-reviewed journals, including Arthritis & Rheumatology, Medical Care, Clinical Immunology Communications, and Journal of General Internal Medicine.
Dr. Sung is a member of the American College of Rheumatology (ACR). -
Ruey J. Sung
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsClinical and basic cardiac electrophysiology
-
Philip Sunshine
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsMy primary interests are in the area of neonatal nutrition and developmental gastroenterology. The use of parenteral nutrition in very low birth weight infants, and the introduction of early enteral feeding to stimulate gastrointestinal maturation are my specific areas of investigative endeavors.
-
John B. Sunwoo, MD
Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy laboratory is focused on two primary areas of research: (1) the immune response to head and neck cancer and to a tumorigenic population of cells within these malignancies called cancer stem cells; (2) the developmental programs of a special lymphocyte population involved in innate immunity called natural killer (NK) cells; and (3) intra-tumor and inter-tumor heterogeneity.
-
Trisha Suppes, MD, PhD
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsLong-term treatment strategies for bipolar disorder, treatment for bipolar II disorder, use of treatment algorithms, and treatment of major depression.
-
Vidyani Suryadevara
Instructor, Genetics
Current Research and Scholarly InterestsA Bioengineer by training, she has a breadth of experiences across different scientific disciplines including pulmonary diseases, Alzheimer’s disease, and musculoskeletal disorders, wherein her research projects involved unraveling signaling mechanism behind the disease in order to identify new therapeutic targets and developing imaging modalities for early diagnosis of the disease, thus eventually improving the quality of life in patients. Her current work has been centered around age-associated pathophysiologies like osteoarthritis and Alzheimer's Disease. Her research currently focuses on the clinical translation of a novel noninvasive multimodality imaging approach to detect senescence in osteoarthritis and Alzheimer's Disease and understand the senescence biology in these age-associated diseases.
She has led teams of renowned senescence scientists across the US to develop expert recommendations for biomarkers for senescence. She is also a faculty fellow in the Center for Innovation at Global Health, wherein her focus is to develop region-specific lifestyle interventions to prevent dementia. -
Rachel Sina Sussman
Adjunct Clinical Instructor, Educational Programs and Services (EPS)
BioDr. Rachel Sussman grew up in Allentown, Pennsylvania and Chicago, and completed college at Yale, a master's degree in psychology at Harvard, and her medical degree at Stanford. She worked and studied for several years in Belgium and China. As a former middle and high school science teacher, she has a strong interest in education and the importance of good communication with patients. She has particular interests in women's health, pediatrics, lactation, and nutrition for the whole family. Her interest in psychology also guided her towards a fellowship at Stanford and expertise in addiction and chemical dependency. Dr. Sussman enjoys biking everywhere she can with her three kids, going to the farmer's market on the weekends, reading, and yoga.
-
Juwono L. Sutedjo, MD, MBA
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sutedjo is a board-certified, fellowship-trained cardiologist. She is a faculty in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Sutedjo holds seven board certifications. She specializes in complex cardiovascular conditions, emphasizing multimodality cardiovascular imaging and disease prevention. She integrates leading-edge diagnostics with evidence-based strategies to provide comprehensive, patient-centered care. She has led multidisciplinary clinics, telehealth programs, and ambulatory operations to enhance accessibility and efficiency.
Dr. Sutedjo has a visionary approach to the future of cardiovascular medicine, particularly in the context of the rapidly evolving digital era. With a clear understanding of the need for innovative business models in healthcare, she pursued an MBA from the Wharton School of the University of Pennsylvania to complement her medical expertise. As a physician executive and clinical researcher, she has deep expertise in clinical operations, health care delivery, and finance. Her diverse background spans private practice, integrated healthcare systems, and managed care settings, providing her with a comprehensive perspective on the healthcare landscape. Driven by a commitment to enhancing patient outcomes, Dr. Sutedjo is deeply invested in leveraging digital health innovations and artificial intelligence to advance the field of cardiovascular care.
Dr. Sutedjo’s research explores AI, machine learning, and digital health applications in cardiovascular risk prediction, diagnosis, and treatment. She aims to improve efficiency, reduce disparities, and enhance precision in clinical decision-making.
Dr. Sutedjo has published her work in Circulation, The American Journal of Medicine, and 21st Century Cardiology. She has also presented at the American Heart Association Scientific Sessions and other national and international conferences, engaging with industry leaders and private sector stakeholders on the role of AI in health care. She has co-founded several health technology startups and served as a consultant for leading technology companies and private sector organizations. Additionally, she played a key role in the IPO of a tech startup on the Toronto Stock Exchange. -
Katherine Sutherland, PA-C
Temporary Employee, Medicine - Med/Blood and Marrow Transplantation
BioKatherine completed her PA degree at Stanford University and worked as a PA in Cutaneous Oncology for 2 years prior to transitioning to Stanford BMT in 2012. Katherine transitioned to part time work in January 2016 and now works on the inpatient service on an as needed basis.
-
Ken Suzuki
Postdoctoral Scholar, General Surgery
BioKen Suzuki is a postdoctoral researcher at Stanford University's Department of Surgery. He received his PhD in Economics from the University of California at Santa Cruz in June 2024. Before UC Santa Cruz, he earned his MA in Economics from Hitotsubashi University in 2017 and his BA in Economics from Yokohama National University in 2015. His research interests include health economics, applied microeconomics, econometrics, and statistical causal inference. His research utilizes large administrative datasets from the Veterans Health Administration (VA) to examine how health policies affect patient healthcare utilization and health outcomes.
-
David Svec, MD, MBA
Clinical Associate Professor, Medicine
Current Research and Scholarly InterestsHigh Value Care: Leading quality improvement projects / research initiatives
-
Katrin J Svensson
Associate Professor of Pathology
Current Research and Scholarly InterestsMolecular metabolism
Protein biochemistry
Cell biology and function
Animal physiology -
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances. -
Andrew Sweatt
Assistant Professor of Medicine (PACCM)
Current Research and Scholarly InterestsAiming to advance understanding and treatment of pulmonary arterial hypertension (PAH), Dr. Sweatt's research leverages high-throughput molecular profiling, deep clinical phenotypic data, and data science (machine learning and network-based analysis) to identify novel sub-phenotypes and therapeutically-relevant biomarkers in PAH.
-
Susan M. Swetter, MD
Mosbacher Professor of Dermatology
Current Research and Scholarly Interests1) Early detection of melanoma through precision screening, novel imaging technologies (including AI), and professional/public education to raise awareness. 2) Therapeutic prevention of melanoma in high-risk groups. 3) Epidemiologic and sociodemographic melanoma risk factor identification. 4) Co-Founder/Director of the national Melanoma Prevention Working Group, an interdisciplinary collaboration dedicated to melanoma control; Founding Director of the Wipe Out Melanoma - California initiative.
-
Alexandra Switzer
Basic Life Research Scientist, Microbiology and Immunology
Current Role at StanfordMicrobiologist, veterinarian and data analyst in the Relman lab studying the indigenous gut microbiota of a wide range of marine and terrestrial mammals. Current research interests include characterizing microbiome assembly in neonatal mammals, host-microbiome co-evolution and patterns of microbiome diversity associated with wildlife population health.
